[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80538]], camposKey:2405-8440 2023-09-01 Safety, biocompatibility, and potential functionality of a new accommodative intraocular lens: An experimental study in rabbits00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75910]], camposKey:2077-0383 2023-03-01 Does PLEX® Elite 9000 OCT Identify and Characterize Most Posterior Pole Lesions in Highly Myopic Patients?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74458]], camposKey:0914-7470 2022-07-01 Factors influencing mesenchymal stromal cells in in vitro cellular models to study retinal pigment epithelial cell rescue10051015, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72047]], camposKey:1662-5129 2022-02-11 Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72049]], camposKey:2164-2591 2021-12-01 Ex-Vivo Method to Quantifiably Evaluate the Staining Effectiveness of Anterior Lens Capsule Dyes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65214]], camposKey:2045-2322 2021-01-12 Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59768]], camposKey:1673-5374 2021-01-01 Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases16311638, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65507]], camposKey:1673-5374 2021-01-01 Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome117118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65911]], camposKey:1687-966X 2020-06-27 Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72052]], camposKey:2329-0501 2020-06-12 Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration11551166, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51256]], camposKey:0273-2300 2020-01-01 Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery1045270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52553]], camposKey:1673-5374 2020-01-01 Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases16311638, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43077]], camposKey:0007-1161 2019-01-01 Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: Failure of another indirect cytotoxicity analysis4954, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43073]], camposKey:0146-0404 2019-01-01 Chemical considerations regarding the H-value methodology and its relation with toxicity determination33633364, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53048]], camposKey:0146-0404 2019-01-01 Clinical characteristics of proven acute intraocular toxicity by perfluorocarbon liquids (PFCL) used in retinal surgery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53049]], camposKey:0146-0404 2019-01-01 Cytotoxicity evaluation of toxic substances identified in recent reported toxic lots of perfluorocarbon liquids used in intraocular surgery in patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49599]], camposKey:0014-4835 2019-01-01 Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51254]], camposKey:1932-6203 2019-01-01 Meta-Analysis of the rs243865 MMP-2 Polymorphism and Age Related Macular Degeneration Risk02136240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51255]], camposKey:1090-0535 2019-01-01 Reliability and reproducibility of a rodent model of choroidal neovascularization based on the subretinal injection of polyethylene glycol194203, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49606]], camposKey:0721-832X 2018-01-01 Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits125134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11666]], camposKey:2045-2322 2018-01-01 Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41425]], camposKey:1673-5374 2018-01-01 Ocular findings in Zucker Diabetic Fatty rats emphasize the key role of neuroglia degeneration in diabetic retinopathy pathophysiology239240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52974]], camposKey:0146-0404 2018-01-01 Toxicity of an endotamponade made by a mixture of perfluorooctane and perfluorohexyloctane evaluated by a new cytotoxicity method00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10084]], camposKey:0275-004X 2017-01-01 Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery11401151, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52640]], camposKey:1755-375X 2017-01-01 Effects of plasma kallikrein inhibitors in an in vitro RPE oxidative stress model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41428]], camposKey:0146-0404 2017-01-01 Histologic characterization of retina neuroglia modifications in diabetic zucker diabetic fatty rats49254933, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39307]], camposKey:0146-0404 2017-01-01 Perfluoro-n-octane cytotoxicity in human retinal pigment epithelial cell culture00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39308]], camposKey:0146-0404 2017-01-01 Perfluoro-n-octane cytoxicity in porcine neuroretina organotypic culture00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74459]], camposKey:1090-0535 2016-03-25 A novel coculture model of porcine central neuroretina expiants and retinal pigment epithelium cells243253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35035]], camposKey:1090-0535 2016-03-25 A novel coculture model of porcine central neuroretina explants and retinal pigment epithelium cells243253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51252]], camposKey:1090-0535 2016-01-01 A novel coculture model of porcine central neuroretina explants and retinal pigment epithelium cells243253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52639]], camposKey:1948-0210 2016-01-01 Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials376383, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10049]], camposKey:0030-3755 2016-01-01 Perfluorocarbon Liquids Toxicity: A Sanitary Alert6363, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51257]], camposKey:2155-9570 2015-01-01 Role of systemic anti-tumour necrosis factor alpha treatment in the reduction of proliferative vitreoretinopathy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49613]], camposKey:2090-004X 2015-01-01 Safety and Biocompatibility of a New High-Density Polyethylene-Based Spherical Integrated Porous Orbital Implant: An Experimental Study in Rabbits00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50771]], camposKey:2211-5420 2014-01-01 Basement membrane promotes ciliary body derived cell spheres formation112118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49616]], camposKey:2314-6133 2014-01-01 Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6905]], camposKey:0302-766X 2014-01-01 Triple-layered mixed co-culture model of RPE cells with neuroretina for evaluating the neuroprotective effects of adipose-MSCs705716, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35038]], camposKey:1090-0535 2013-01-01 Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina894903, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38600]], camposKey:0022-1759 2013-01-01 Flow cytometry assessment of the purity of human retinal pigment epithelial primary cell cultures6168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35037]], camposKey:0014-4835 2012-01-01 Time course modifications in organotypic culture of human neuroretina2638, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=317]], camposKey:1549-3296 2011-01-01 Elastin-like recombinamers as substrates for retinal pigment epithelial cell growth243250, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9484]], camposKey:0721-832X 2011-01-01 The parameters of the porcine eyeball475482, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38602]], camposKey:0014-4835 2011-01-01 Trypan Blue staining method for quenching the autofluorescence of RPE cells for improving protein expression analysis956962, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35039]], camposKey:1090-0535 2008-01-01 Muller and macrophage-like cell interactions in an organotypic culture of porcine neuroretina21482156][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=18511]},camposKey: 301 306 Perros guía en la discapacidad visual 8498358493Manual de Baja Visión y Rehabilitación Visual 1 null Editorial Médica Panamericana , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29657]},camposKey: 1146 1146 Design, development, and implementation of non-face-to-face dynamization strategies in a Master¿s in science subject 8409424843EDULEARN22 Proceedings 1 2022-01-01 IATED Academy , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=3438]},camposKey: 68 69 Seguridad y tolerancia de la inyección intravítrea de células madre mesenquimales en conejos 8497737342Actas del XX Congreso Internacional de la Sociedad Española de Cirugía Veterinaria (SECIVE), Facultad de Veterinaria, Universidad de León 19-20 junio de 2015 1 2015-01-01 Servicio de Publicaciones ][][][com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=432]]][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63712]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63712]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=203]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=202]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=201]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=200]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=203]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=202]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=201]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=200]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30474]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638977]]][][][][][][com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=556]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=552]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=551]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=553]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=554]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=555]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=557]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=558]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=559]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=560]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=561]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=562]]][GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=40 ] ]][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@26789ba2, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@78f7ed57, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7fecb8c4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@514c97ae, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@338bb3ae, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@74517ddd, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6ee1c10b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5b25ca9e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@355d0497, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4a1d3874, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2a1441a5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5f901f43, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2b4d19a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@21c99720, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@29d8f3d5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@766d8baa, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@52f1bcfc, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3f6c4115, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@51445b76, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4b6eba2f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1427f9e2, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@491e769a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3af20b24, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4737197, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2fb07012, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@15a079d8, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3fa1eb63, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@20c1dac9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@c5d1e23, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1aa5c8c9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2a6fd20d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4d6421b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@609ee8a4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@54c997fe, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@e2d8d0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3692944d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@215e81f3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@39309441, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2f82efef, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@d1036ae, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@58947fe6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@65bb6a29, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5dfe0ce6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@51d7f4b1, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2ac7da22, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@14931771, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3927a039, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@57bbb9d0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@43b96fcf, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4f9dd056][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f96ae, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f869e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f88df, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f93c1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8674, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8c57, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8ac6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f88a7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8336, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f944b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8c7c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f876e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8773, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f93e1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f96d1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8b80, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8605, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8cd0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8a84, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f94b4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9409, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f88bc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f85de, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f85db, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8bf7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f87fd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8c27, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8b4b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9380, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8bb6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8e8b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f982a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8dbe, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f868a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8f2d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8a1c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f85c8][com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2026]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2034]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2018]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2033]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2024]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2032]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2025]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2028]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2021]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2027]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2022]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2023]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2017]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2031]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2020]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2030]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2035]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2029]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2019]]][com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2026]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2034]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2018]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2033]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2024]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2032]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2025]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2028]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2021]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2027]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2022]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2023]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2017]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2031]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2020]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2030]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2035]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2029]], com.sigma.fs3.argos.domain.gpc.GpcCursosSeminaris[id=com.sigma.fs3.argos.domain.gpc.GpcCursosSeminarisPK[ifcactivitat=CUR, ifccomptador=2019]]][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=61710]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=60941]]][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=61710]], com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.gpc.GpcEstadesForaPK[ifcactivitat=ESF, ifccomptador=60941]]][com.sigma.fs3.argos.domain.gpc.GpcExpGestionId[id=com.sigma.fs3.argos.domain.gpc.GpcExpGestionIdPK[ifcactivitat=EXP, ifccomptador=308]]][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1460]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1005]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1301]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@465521], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56fe39], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56fc62], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46595b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c00], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c25], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414d42], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5be8a9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413bdc], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412533]][][CatedrasConvenios{id=22, codigoPersona=com.sigma.fs3.argos.domain.gpc.PersonalGPC[ifcidPers=23489], codigoTipo=CAT, codigoContable=null, titulo=CÁTEDRA ZEISS EN LA UNIVERSIDAD DE VALLADOLID, fechaInicio=2017-09-01, fechaFin=null, importe=12100.0, visiblePortal=1, visibleCvn=1, visibleMemoria=1, validado=S}][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16cf8, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15e7b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@155c4][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=31131]},camposKey: 43 0 Caracterización de la autofagia en un modelo in-vitro deneurodegeneración retiniana 8412292766La madre de los aires 1 2021-01-01 Fundación 3CIN , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=31130]},camposKey: 86 0 Evaluación de la necroptosis en un modelo organotípico e neurodegeneración retiniana 8412292766La madre de los aires 1 2021-01-01 Fundación 3CIN ]
